Your browser doesn't support javascript.
loading
Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.
Ravi, Saranya; Schuck, Robert N; Hilliard, Eleanor; Lee, Craig R; Dai, Xuming; Lenhart, Kaitlin; Willis, Monte S; Jensen, Brian C; Stouffer, George A; Patterson, Cam; Schisler, Jonathan C.
Afiliação
  • Ravi S; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Schuck RN; Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Hilliard E; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Lee CR; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Dai X; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Eshelman School of Pharmacy, the Division of Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Lenhart K; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Willis MS; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Pharmacology, The University of North Carolina at Cha
  • Jensen BC; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Eshelman School of Pharmacy, the Division of Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Pharmacology, The University of North Carolin
  • Stouffer GA; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Eshelman School of Pharmacy, the Division of Cardiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Patterson C; Presbyterian Hospital/Weill-Cornell Medical Center, New York, New York.
  • Schisler JC; McAllister Heart Institute, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Pathology and Laboratory Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Department of Pharmacology, The University of North Carolina at Cha
Am J Pathol ; 187(12): 2895-2911, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29153655
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Quimiocina CXCL5 Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Am J Pathol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Quimiocina CXCL5 Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Am J Pathol Ano de publicação: 2017 Tipo de documento: Article